Sten R. Sörensen

Born 1959. Sten R. Sörensen has extensive expe­rience from the pharma, biotech, and finance industries. Before Cereno, he held senior positions in major pharma including Head of International Marketing Operations for the pharma portfolio at Monsanto and Global Marketing Director for the portfolio of Secondary Prevention Products, Cardiovasculars at AstraZeneca. At Monsanto and AstraZeneca, he initiated two ground­breaking preventive survival studies in heart failure, RALES and MERIT-HF, both establishing a paradigm shift for mineralocorticoid receptor (MR) antagonism and beta-blocker drug therapies in heart failure, sig­nificantly improving quality of life and life expectancy. He is Chairman of SARomics Biostructure and Board Member of SynAct Pharma. Sten R. Sörensen holds a bachelor’s degree in chemistry from Lund University.